Stem Cell Clinic Publishes First Peer Reviewed Paper on Autism Stem Cell Therapy

SAN DIEGO--(BUSINESS WIRE)--The Institute for Cellular Medicine (www.cellmedicine.com) announced today what appears to be the first publication in a peer reviewed journal outlining scientific rationale for the use of stem cells in the treatment of autism.

“The application of stem cell therapy to autism, a condition affecting approximately 1 in 144 children, offers the possibility of addressing the root cause of this disorder”

“The application of stem cell therapy to autism, a condition affecting approximately 1 in 144 children, offers the possibility of addressing the root cause of this disorder,” said Dr. Gang Chen, one of the International Scientific Advisors for the Institute of Cellular Medicine. He continued, “While numerous clinics have used adult stem cells therapeutically for years, none of these clinics make it a priority to publish in the peer reviewed literature the scientific basis for their work and findings. As a result, anecdotal findings and observations which would have great value to academic researchers are largely ignored. We hope to correct this.”

The publication, entitled “Stem cell therapy for autism,” was published in the Journal of Translational Medicine and is freely available online at http://www.translational-medicine.com/content/pdf/1479-5876-5-30.pdf. A video summary of the paper may be seen at http://www.youtube.com/watch?v=FlSaXCzLW6w.

“While embryonic stem cells are receiving the spotlight of the mass media, fears of carcinogenesis, immune rejection and lack of differentiation have blocked these cells from clinical use to date. In sharp contrast, adult stem cell therapy, which does not involve destruction of fetuses has demonstrated great success in various US and European clinical trials for conditions such as heart failure, liver cirrhosis, and Crohn’s disease. In fact, companies such as Osiris Therapeutics are already in Phase III FDA registration trials for their adult mesenchymal stem cell therapy product. By this publication, we hope to extend current clinical research of adult stem cells to autism,” concluded Dr. Chen.

About the Institute for Cellular Medicine

The Institute for Cellular Medicine is an international organization offering adult stem cell therapy for a variety of degenerative conditions ranging from multiple sclerosis, to rheumatoid arthritis, to heart failure. More information may be found at www.cellmedicine.com.